. TGF␤ signaling in lung epithelium regulates bleomycin-induced alveolar injury and fibroblast recruitment. Am J Physiol Lung Cell Mol Physiol 300: L887-L897, 2011. First published March 25, 2011; doi:10.1152/ajplung.00397.2010The response of alveolar epithelial cells (AECs) to lung injury plays a central role in the pathogenesis of pulmonary fibrosis, but the mechanisms by which AECs regulate fibrotic processes are not well defined. We aimed to elucidate how transforming growth factor-␤ (TGF␤) signaling in lung epithelium impacts lung fibrosis in the intratracheal bleomycin model. Mice with selective deficiency of TGF␤ receptor 2 (TGF␤R2) in lung epithelium were generated and crossed to cell fate reporter mice that express ␤-galactosidase (␤-gal) in cells of lung epithelial lineage. Mice were given intratracheal bleomycin (0.08 U), and the following parameters were assessed: AEC death by terminal deoxynucleotidyl transferase dUTP-mediated nick-end labeling assay, inflammation by total and differential cell counts from bronchoalveolar lavage, fibrosis by scoring of trichromestained lung sections, and total lung collagen content. Mice with lung epithelial deficiency of TGF␤R2 had improved AEC survival, despite greater lung inflammation, after bleomycin administration. At 3 wk after bleomycin administration, mice with epithelial TGF␤R2 deficiency showed a significantly attenuated fibrotic response in the lungs, as determined by semiquantitatve scoring and total collagen content. The reduction in lung fibrosis in these mice was associated with a marked decrease in the lung fibroblast population, both total lung fibroblasts and epithelial-to-mesenchymal transition-derived (S100A4 ϩ
ϩ /␤-gal ϩ ) fibroblasts. Attenuation of TGF␤ signaling in lung epithelium provides protection from bleomycin-induced fibrosis, indicating a critical role for the epithelium in transducing the profibrotic effects of this cytokine. epithelial mesenchymal transition; transforming growth factor-␤; S100A4; pulmonary fibrosis IDIOPATHIC PULMONARY FIBROSIS (IPF) remains a progressive and relentless restrictive lung disease for which there is no cure or effective therapy short of lung transplantation (1, 15) . Current thoughts on the pathogenesis of disease in IPF include prominent roles for alveolar epithelial cell (AEC) injury and fibroblast activation. Over the past two decades, the role of the fibroblast in this disease process has been extensively studied, and it is clear that these cells are responsible for the collagen and other extracellular matrix deposition that occurs in IPF.
Recently, the role of the AEC population in this disease process has also been prominently addressed and defined.
Multiple lines of evidence implicate the AEC as a pivotal cell type in the fibrotic response in IPF (42) . In IPF biopsies, epithelial abnormalities are common and include hyperplastic AECs lining areas of honeycombing (39) . Mutations in surfactant protein (SP) C (SP-C) and SP-A linked to IPF highlight the importance of type II AECs in disease pathogenesis (12, 48, 54) . AEC apoptosis has been implicated in lung fibrosis on the basis of human disease and animal models (49) . Furthermore, AECs produce key profibrotic cytokines, including transforming growth factor-␤ (TGF␤), connective tissue growth factor, and platelet-derived growth factor (2, 22, 38) . However, the role of the alveolar epithelium in modulating the fibrotic response requires further investigation.
In addition to epithelial cells, TGF␤ is produced by many other cells in the lung, including fibroblasts and inflammatory cells. TGF␤ pathway signaling occurs when TGF␤ binds at the cell surface to the major TGF␤ receptor (TGF␤R2), which then recruits TGF␤R1 to form a heterodimer (14) . The kinase activity of TGF␤R2 phosphorylates TGF␤R1, which in turn leads to activation of smad2 and smad3 signaling (17, 36, 57) . Once in the nucleus, smad2 and smad3 (in conjunction with smad4) can activate transcription of multiple genes (3, 21) . Deficiency of TGF␤R2 disrupts the TGF␤ signaling pathway (4, 9) .
TGF␤ is a key profibrotic cytokine in humans and animals. Transgenic or adenoviral vector-mediated overexpression of TGF␤ in the lungs results in fibrosis in mouse models (25, 32, 44, 55) . TGF␤ promotes fibroblast proliferation and activation and is one of the most important stimulators of extracellular matrix production (43) . In addition to stimulating fibroblasts, TGF␤ signaling can affect epithelial cells by enhancing cell death (32) and inducing epithelial-mesenchymal transition (EMT) (23, 47, 56) . In these studies, we sought to dissect the pivotal cellular targets for TGF␤ signaling in the lungs by evaluating the role and importance of AECs in mediating the profibrotic effects of TGF␤. To address this issue, we developed a transgenic murine model in which TGF␤R2 is specifically deleted in lung epithelium. While mice with lung epithelial cell deficiency of TGF␤R2 have slightly greater alveolar space than controls and otherwise grow normally into adulthood, these mice are protected from bleomycin-induced AEC injury and fibrosis. Together, our studies define a critical role for lung epithelium in transducing the profibrotic effects of TGF␤.
MATERIALS AND METHODS
Transgenic mice. Transgenic mice from the C57BL/6J background weighed 20 -30 g and were Ն8 wk old at the beginning of the study. Transgenic mice expressing Cre recombinase under control of the 3.7-kb human SP-C promoter (SPC.Cre) were obtained from Dr. Brigid Hogan (Duke University, Durham, NC). R26Rosa.Stop.lacZ reporter mice were obtained from Jackson Laboratories (Bar Harbor, ME). With these mice, the R26Rosa endogenous promoter drives expression of a construct that consists of a loxP-flanked STOP cassette upstream of lacZ [whose gene product is ␤-galactosidase (␤-gal)] and a polyadenylation sequence (46) . SPC.Cre mice were mated to R26Rosa.Stop.lacZ reporter mice, resulting in SPC.Cre.R26Rosa.Stop.lacZ mice, which serve as a lung epithelium cell fate reporter system, as described previously (13, 47) . Transgenic mice in which the major receptor for TGF␤ (TGF␤R2) is flanked by loxP sites were obtained from Dr. Hal Moses (Vanderbilt University), and these TGF␤R2 fl/fl mice were crossed to the cell fate reporter mice described above, yielding the triple-transgenic model SPC.Cre.TGF␤R2 fl/fl .R26Rosa.Stop.lacZ. Mice were housed in the central animal care facility at Vanderbilt University Medical Center and given food and water ad libitum. The experimental protocol was reviewed and approved by the Institutional Animal Care and Utilization Committee at Vanderbilt University.
Bleomycin model. Bleomycin (Teva Parenteral Medicines, Irvine, CA) was prepared and administered by an intratracheal intubation procedure at a dose of 0.08 U in a total volume of 100 l of sterile saline, as previously described (13) . At designated times after bleomycin administration, mice were euthanized by exposure to carbon dioxide, and lungs were harvested for histological preparations and frozen tissue, or bronchoalveolar lavage (BAL) was performed as described below and elsewhere (13, 30, 31, 47) .
Histology and microscopy. For tissue harvesting, the lungs were perfused with normal saline from the right to the left ventricle of the heart. The right hilum was identified, tied off, and surgically removed; the lobes were flash-frozen immediately in liquid nitrogen and stored at Ϫ70°C. The trachea was isolated, and with use of a blunt-tipped needle and syringe, the remaining left lung was inflated with 10% neutral buffered formalin by a 25-cm pressure column. The trachea was tied off, and the lung was removed for fixation overnight in formalin and then embedded in paraffin. Sections (5 m) were cut for hematoxylin-eosin and trichrome blue staining, as well as for immunohistochemistry studies. For cell fate mapping, frozen sections were processed as previously described (47) . Briefly, lungs were perfused with normal saline and then inflated with 4% paraformaldehyde by a 25-cm pressure column. The trachea was tied off, and the lungs were kept in 4% paraformaldehyde for 2 h at 4°C and then transferred into a 20% sucrose solution for 24 h. Then the lungs were flash-frozen in liquid nitrogen and transferred to a Ϫ70°C freezer until processed on a cryostat for frozen tissue sectioning. Light and fluorescence microscopy was performed using an inverted research microscope (model IX81, Olympus, Tokyo, Japan) configured with a biological disk scanning unit (model IX2, Olympus).
Lung lavage and cell counts. BAL was performed as described previously (13, 30) . After euthanasia, three 800-l lavages of sterile saline were performed using a 20-g blunt-tipped needle inserted into the trachea. Samples were centrifuged at 400 g for 10 min, and the supernatant was discarded. Cell counts were performed manually under light microscopy using a hemocytometer. A Cytospin 2 (Shandon Southern Products) was used to load ϳ30,000 cells from each specimen onto slides. These slide preparations were stained using a modified Wright stain and viewed under light microscopy for differential white blood cell counts.
Type II AEC isolation. Type II AECs were isolated from adult transgenic mice, as described elsewhere (31, 47) . Isolation of type II AECs with the cell fate-mapping construct has been Ͼ95% Xgalpositive, indicative of epithelial cell lineage, and Ͼ90% pro-SP-Cpositive by immunohistochemistry, indicative of type II AECs. After isolation, type II AECs were cultured in DMEM for use in experiments. In one set of experiments, AECs were placed in culture medium; after 24 h, TGF␤1 (10 ng/ml; R & D Systems, Minneapolis, MN) was added to the culture medium for 2 h, and the cells were fixed with formalin, as previously described (31) .R26Rosa.Stop.lacZ). Statistical analysis was performed using manufacturer-provided software (SABiosciences), with P Ͻ 0.05 considered significant.
Immunofluorescence staining. Immunofluorescence was performed on frozen lung sections as previously described (13, 47) . Frozen lung tissue blocks were cut into 5-m sections and fixed in 0.2% paraformaldehyde in PIPES buffer [0.1 M PIPES (Sigma, St. Louis, MO), 2 mM MgCl2, and 5 mM EGTA]. After the sections were blocked with 3% BSA, they were incubated with primary antibodies against S100A4 (nonbiotinylated rabbit polyclonal antibody; obtained from Dr. Eric Neilson, Vanderbilt University) and ␤-gal (chicken polyclonal antibody; Abcam, Cambridge, MA) at 4°C overnight. After the sections were washed with phosphate-buffered saline, they were stained with fluorescent secondary antibodies (Jackson Immunoresearch, West Grove, PA). Immunofluorescence was also performed on isolated type II AECs for TGF␤R2 (goat polyclonal antibody; Santa Cruz Biotechnology, Santa Cruz, CA) and phosphorylated smad2 (rabbit polyclonal antibody; Santa Cruz Biotechnology) in conjunction with fluorescent secondary antibodies (Jackson Immunoresearch). For tissue and cell preparations, nuclear staining was done with 4=,6-diamidino-2-phenylindole using Vectashield mounting medium (Vector Laboratories).
TUNEL and lactate dehydrogenase cytotoxicity assays. Terminal deoxynucleotidyl transferase dUTP-mediated nick-end labeling (TUNEL) assays on lung sections were performed as previously described (13) using a commercially available kit in accordance with the manufacturer's directions (In Situ Cell Death Detection Kit, Roche Molecular Biochemicals, Indianapolis, IN). Counterstains for preparations were performed with hematoxylin. Isolated type II AECs from untreated mice were placed in culture medium and, 24 h later, exposed to bleomycin (0.1 U in 2 ml) in the culture medium for 24 h; then media supernatant and cell lysates were collected for determination of cytotoxicity using a lactate dehydrogenase (LDH)-based assay according to the manufacturer's instructions (Cytox 96 Non-Radioactive Cytotoxicity Assay, Promega, Madison, WI). For these studies, percent cytotoxicity was calculated as LDH in supernatant divided by total LDH (supernatant ϩ lysate). Samples were run in triplicate, with the mean representing the score for an individual mouse type II AEC isolation.
LacZ staining. Xgal substrate staining on lung tissues and cells was performed as previously described (13, 47) . Frozen lung tissue sections were fixed in LacZ fixative solution containing 0.2% glutaraldehyde, 5 mM EGTA (pH 7.3), and 100 mM MgCl2 in 0.1 M NaPO4 (pH 7.3) for 15 min at 4°C, washed three times in phosphate-buffered saline, and incubated at 37°C in 1 mg/ml Xgal (Sigma), 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 2 mM MgCl2, 0.2% Nonidet P40, and 0.1% sodium deoxycholate in phosphate-buffered saline for 16 h. Sections were counterstained with eosin and mounted with Permount (Sigma).
Semiquantitative scoring. Lung fibrosis on histological specimens was quantified by an investigator blinded to the group using a semiquantitative score, as previously described (13, 30) . Briefly, slides were evaluated on 10 sequential, nonoverlapping fields (ϫ300 magnification) of lung parenchyma from each specimen. Lung fibrosis was evaluated on trichrome-stained lung sections using a 0 -4 point scale, with a score of 0 for normal lung architecture, 1 for increased thickness of some (Յ50%) interalveolar septa, 2 for thickening of Ͼ50% of interalveolar septa without formation of fibrotic lesions, 3 for thickening of the interalveolar septa with formation of isolated fibrotic lesions, and 4 for formation of multiple fibrotic lesions with total or subtotal distortion of parenchymal architecture. The mean score for the 10 fields represented the score for each individual specimen. For evaluation of TUNEL staining, the percentage of cells with TUNEL-positive nuclei on 10 sequential, nonoverlapping highpower fields from each specimen was recorded. The mean percentage of TUNEL-positive cells on 10 sequential fields represented the score for each individual specimen. For quantitation of immunofluorescence-positive cells in tissue preparations, green fluorescent, red fluorescent, and dual-fluorescent cells were counted on 10 nonoverlapping high-power fields at ϫ600 magnification. The average number, as well as mean percentage, represented the score for each individual specimen.
Lung collagen content determination. Frozen tissue samples from the right upper and right middle lung lobes were combined into a single sample and hydrolyzed in 6 N HCl, and hydroxyproline content was quantitated using a microplate assay based on the Ehrlich reaction, as previously described (7). Lung collagen content was calculated from these results, as hydroxyproline accounts for ϳ13.3% of collagen by weight.
Morphometry measurements. To analyze lung morphometry, alveolar diameter and alveolar perimeter were measured in hematoxylineosin-stained lung tissue sections using a computerized image analyzer system (Image-Pro Express, Media Cybernetics, Silver Spring, MD). Ten nonoverlapping digital images were prepared starting from the apex of each tissue section (ϫ40 objective). Alveolar diameter was calculated as an average of four measurements taken at 45°angles for each alveolus in the field. Alveolar perimeter was measured as the length of the inner edge of each alveolus in the field. All measurements were made by a pathologist blinded to study group and reported in micrometers.
Statistics. Statistical analyses were performed using GraphPad InStat (GraphPad Software, San Diego, CA). Differences among groups were assessed using one-way ANOVA or Kruskal-Wallis rank ANOVA. Differences between pairs were assessed using a Student's t-test or a Mann-Whitney test. Survival differences were evaluated using a Fisher's exact test. Results are presented as means Ϯ SE. P Ͻ 0.05 was considered significant.
RESULTS
Mice with selective deletion of TGF␤R2 in lung epithelium are developmentally normal. For these studies, we developed a transgenic murine model in which TGF␤R2 can be selectively deleted in lung epithelium. SPC.Cre mice were crossed to Rosa.Stop.lacZ mice, as we reported previously (47) . Because of SP-C expression during lung development, all lung epithelial cells from the trachea to the alveolus have ␤-gal expression in these mice, allowing for lung epithelial cell fate-mapping studies. Next, double-transgenic mice were crossed to TGF␤R2 (Fig. 1B) . Xgal staining was identified in airway and alveolar epithelium. In addition, type II AECs isolated from these mice also stained for Xgal (Fig. 1, C and D) , but not for TGF␤R2 (Fig. 1, E and F) . When these primary type II AECs were exposed to TGF␤ in vitro, phosphorylated smad2 immunofluorescence was readily detected in AECs from the nonfloxed littermate controls, whereas type II AECs with deficiency of TGF␤R2 failed to induce phosphorylated smad2 (Fig. 1, G and  H ). These studies demonstrate selective deficiency of TGF␤R2 in lung epithelium while maintaining cell fate-mapping capabilities.
Pups containing the SPC.Cre.TGF␤R2
fl/fl .Rosa.Stop.lacZ constructs appeared normal at birth and through adulthood, had no evidence of respiratory distress, and reproduced normally. On gross histological examination, lung architecture appeared normal (Fig. 2, A and B) , but when morphometric modalities were employed, alveolar size was slightly enlarged in mice with lung epithelial cell deficiency of TGF␤R2 compared with wild-type littermates on the basis of measurements of alveolar diameter and alveolar perimeter (Fig. 2, C and D) . Since there was no evidence of an alveolar destructive process, this finding was interpreted as alveolar space enlargement, rather than true emphysema. Except for this morphometric difference, there was no other evidence that lung epithelial cell deficiency of TGF␤R2 affected other aspects of development, survival, or overall condition of these mice.
To further characterize the integrity of the model, we sought to examine the downstream differential effects of AEC-specific deletion of TGF␤R2 on TGF␤-dependent mediator production. We isolated type II AECs from SPC.Cre.TGF␤R2 fl/fl .Rosa. Stop.lacZ mice and littermate controls at 2 wk after bleomycin administration, at which time lung TGF␤ levels are elevated (18) . After AEC isolation, we performed a targeted TGF␤/ BMP-specific 96-well array (SABiosciences) to evaluate expression of TGF␤/BMP-dependent genes. As summarized in Table 1 , expression of a number of TGF␤-regulated genes (17 of 84) was reduced in AECs isolated from SPC.Cre.TGF␤R2 fl/fl . Rosa.Stop.lacZ mice compared with littermate controls. These results demonstrate that this model of cell-specific deletion of TGF␤R2 blocks TGF␤-dependent gene expression in AECs.
Mice with deficiency of TGF␤R2 in lung epithelium have lower mortality, less AEC death, and greater lung inflammation following intratracheal bleomycin administration. To investigate the impact of epithelial TGF␤ signaling on lung injury and remodeling, we treated mice with lung epithelial cell TGF␤R2 deficiency and littermate controls with intratracheal bleomycin. After administration of 0.08 U of bleomycin, all mice with lung epithelial cell TGF␤R2 deficiency survived, while the wild-type controls experienced 36% mortality by week 3 (P Ͻ 0.05, by Fisher's exact test).
AEC apoptosis has been prominently implicated in pulmonary fibrosis. To determine if attenuation of TGF␤ signaling in lung epithelium impacted AEC apoptosis following bleomycin, lungs were harvested at baseline and at 1 wk after bleomycin administration, and sections were analyzed by TUNEL assay. In untreated animals, no difference was noted between groups, as TUNEL-positive cells were very rare at baseline in the lungs of mice with lung epithelial cell TGF␤R2 deficiency and littermate controls. At 1 wk after bleomycin administration, . E and F: immunofluorescence (green) for TGF␤R2 demonstrated that TGF␤R2 expression was absent in type II AECs isolated from mice with TGF␤R2 deleted from lung epithelium (F) but was readily observed in type II AECs isolated from littermate controls (E). G and H: isolated type II AECs were exposed to TGF␤ (10 ng/ml), and immunofluorescence (red) was performed for phosphorylated smad2 (psmad2). There was evidence of pmad2 expression in many of the AECs from mice with intact lung epithelial cell TGF␤R2, while psmad2 expression was markedly attenuated in AECs from mice with TGF␤R2 deficiency in lung epithelium.
mice with TGF␤R2 deficiency in lung epithelium had markedly fewer TUNEL-positive epithelial cells than littermate controls (Fig. 3, A-C) , illustrating that TGF␤ signaling in lung epithelium contributes to AEC death in the bleomycin model. When type II AECs were isolated from the transgenic mice and exposed to bleomycin in vitro for 24 h, a trend toward greater AEC death was noted in mice with intact AEC expression of TGF␤R2 than in AECs with deficiency of TGF␤R2, as determined by LDH cytotoxicity assay (Fig. 3D) .
Because of its known anti-inflammatory effects, we next wanted to determine if interrupting TGF␤ signaling in lung epithelium would impact lung inflammation after bleomycin administration. For these studies, BAL was performed at baseline and 2 wk after bleomycin administration, and cell counts and differentials were performed. In the untreated state, total BAL leukocytes, macrophages, neutrophils, and lymphocytes were similar between mice with lung epithelial cell TGF␤R2 deficiency and littermate controls (Fig. 4) . At Fig. 2 . Mice with deficiency of TGF␤R2 in lung epithelium had normal-appearing lung architecture on gross examination of histology but, by morphometric measurements, had slightly enlarged alveolar spaces compared with controls. A and B: hematoxylineosin-stained sections of lung from a mouse with intact TGF␤R2 in lung epithelium and a mouse with TGF␤R2 deficiency in lung epithelium. Magnification ϫ100. C and D: in mice with TGF␤R2 deficiency in lung epithelium, mean alveolar diameter and mean alveolar perimeter were slightly increased relative to littermate controls (n ϭ 3 in each group). *P Ͻ 0.05 vs. TGF␤R2.Rosa. (Fig. 4, A and  B) . However, total BAL neutrophils and lymphocytes were greater in mice with lung epithelial cell deficiency of TGF␤R2 than in littermates with intact TGF␤R2 expression (Fig. 4, C and D) . Taken together, these studies show that TGF␤ signaling in AECs has opposing effects on epithelial No statistical difference in cell death was noted between AECs in the untreated state or after exposure to bleomycin (n ϭ 3 mice in each group). #P Ͻ 0.05, untreated vs. bleomycintreated AECs from control mice. *P ϭ 0.1 between both groups of AECs treated with bleomycin. Fig. 4 . Lung inflammation was increased in mice with TGF␤R2 deficiency in lung epithelium following intratracheal bleomycin administration. At baseline, total bronchoalveolar lavage (BAL) leukocytes, macrophages, neutrophils, and lymphocytes were similar between mice with TGF␤R2 deficiency in lung epithelium and controls. After bleomycin administration, mice with lung epithelial cell TGF␤R2 deficiency had similar numbers of total BAL leukocytes (A), similar numbers of total BAL macrophages (B), greater numbers of total BAL neutrophils (C), and greater numbers of total BAL lymphocytes (D) than mice with intact TGF␤R2 in lung epithelium (n ϭ 3 untreated mice and 5 bleomycin-treated mice). *P Ͻ 0.05 vs. TGF␤R2.Rosa. For TGF␤R2.Rosa and SPC.Cre.TGF␤R2.Rosa mice, BAL total leukocytes, macrophages, neutrophils, and lymphocytes increased after bleomycin administration (P Ͻ 0.05).
cell survival and inflammation in response to bleomycin treatment.
Mice with deficiency of TGF␤R2 in lung epithelium have attenuated lung fibrosis and decreased numbers of lung fibroblasts. At 3 wk after bleomycin administration, lungs from SPC.Cre.TGF␤R2 fl/fl .Rosa.Stop.lacZ mice and littermate controls were harvested to evaluate development of lung fibrosis. As noted on trichrome-stained lung sections, mice with lung epithelial cell deletion of TGF␤R2 were relatively protected from bleomycin-induced lung fibrosis. SPC.Cre.TGF␤R2 fl/fl . Rosa.Stop.lacZ mice had less architectural distortion and smaller fibrotic areas than littermates (Fig. 5, A and B) , with reduced lung fibrosis by semiquantitative scoring and lung hydroxyproline quantitation (Fig. 5, C and D) .
TGF␤ has a significant impact on the lung fibroblast population, including effects on fibroblast recruitment and activation. Recently, it has been shown to regulate EMT in the lungs (56), a process by which epithelial cells can directly contribute to the lung fibroblast population (13, 23, 24, 47) . In previous studies, we showed a peak in the number of S100A4 ϩ lung fibroblasts at 2 wk after bleomycin administration (31, 47) . For these experiments, we harvested lungs for frozen section from SPC.Cre.TGF␤R2 fl/fl .Rosa.Stop.lacZ and SPC.Cre.Rosa.Stop. lacZ (control) mice, allowing us to maintain cell fate-mapping capabilities in mice with and without lung epithelial cell TGF␤R2 deficiency. Immunofluorescence for ␤-gal (indicative of lung epithelial cell origin) and the fibroblast markers S100A4, vimentin, and ␣-smooth muscle actin (␣-SMA) was performed. Detection of EMT-derived fibroblasts was suboptimal with vimentin and ␣-SMA. Immunofluorescence for vimentin lacked specificity because of high levels of background staining. With immunofluorescence for ␣-SMA, EMTderived ␣-SMA-positive cells were rare in the lung after bleomycin administration in both groups. In contrast, S100A4 served as a better marker for this evaluation. At baseline, dual ␤-gal ϩ /S100A4 ϩ cells were very rarely encountered in SPC.Cre.TGF␤R2 fl/fl .Rosa.Stop.lacZ or SPC.Cre.Rosa.Stop. lacZ mice. However, at 2 wk following bleomycin administration, mice with intact lung epithelial cell TGF␤R2 expression had more lung fibroblasts (based on S100A4 expression) and more EMT-derived fibroblasts (dual ␤-gal ϩ /S100A4 ϩ cells) than mice with lung epithelial cell TGF␤R2 deficiency (Fig. 6) . Taken together, these results demonstrate that lung epithelial cell TGF␤ signaling impacts epithelial cell-fibroblast interactions and fibroblast recruitment, modulating the degree of extracellular matrix deposition and regulating the degree of lung fibrosis after bleomycin administration.
DISCUSSION
Over the past two decades, multiple lines of evidence have shown that AECs have a pivotal role in the pathogenesis of pulmonary fibrosis. Furthermore, over this same time period, TGF␤ has been clearly implicated as a principal profibrotic cytokine involved in the regulation of lung fibrosis. Here, we define the intersection of lung epithelial control of fibrotic remodeling and TGF␤ pathway signaling in the bleomycin model of pulmonary fibrosis. Deficiency of TGF␤R2 in lung epithelium was found to be protective from bleomycin-induced lung fibrosis. Furthermore, lung epithelial cell TGF␤R2 deficiency was associated with less AEC death, increased lung inflammation, and attenuation of fibroblast numbers, including fibroblasts derived via EMT, in mice treated with intratracheal bleomycin compared with wild-type controls. With this model, TGF␤R2 is deleted in the entire lung epithelium, so it is possible that TGF␤ signaling in the epithelium at several Fig. 5 . Lung fibrosis was attenuated in mice with TGF␤R2 deficiency in lung epithelium at 3 wk after bleomycin administration. A and B: representative images of trichromestained lung sections from a mouse with intact TGF␤R2 expression in lung epithelium and a mouse with TGF␤R2 deficiency in lung epithelium. Magnification ϫ400. C: lung fibrosis scored on trichrome bluestained lung sections reveals a lower score with deficiency of TGF␤R2 in lung epithelium (n ϭ 9 TGF␤R2.Rosa mice and 12 SPC.Cre.TGF␤R2.Rosa mice). *P Ͻ 0.05 vs. TGF␤R2.Rosa. D: microplate hydroxyproline assay reveals lower lung lobe (right upper lobe ϩ right middle lobe) collagen content in lungs from mice with deficiency of TGF␤R2 in lung epithelium at 3 wk after bleomycin administration (n ϭ 4 untreated and 7 bleomycin-treated mice). *P Ͻ 0.05 between bleomycin-treated mice. #P Ͻ 0.05, untreated vs. bleomycin-treated TGF␤R2.Rosa. different levels of the tracheobronchial tree, not just the AEC population, contributes to lung fibrosis.
On the basis of reports from the evaluation of human IPF lung tissue and experimental animal models, TGF␤ appears to be the principal profibrotic cytokine involved in the pathogenesis of pulmonary fibrosis. TGF␤ expression has been shown to be upregulated in lung biopsies from individuals with IPF, and immunohistochemistry studies have localized TGF␤ to areas of fibroblastic foci (6, 10, 22) . Furthermore, animal models have greatly delineated the profibrotic nature of TGF␤ in experimental lung fibrosis. TGF␤ expression is increased in the lungs of mice following exposure to bleomycin, and inhibition of TGF␤ pathways attenuates the severity of bleomycininduced lung fibrosis, as demonstrated by studies using a soluble TGF␤ receptor (52) or a TGF␤R1 inhibitor (5) . Prior studies have demonstrated that epithelial expression of TGF␤ induces fibrotic remodeling in the lungs. Delivery of an adenovirus expressing active TGF␤ into the lung, an approach first reported by Sime et al. in 1997 (44) , results in significant lung fibrosis in rats and mice (25, 44, 55) . In addition, Lee et al. (32) showed that expression of active TGF␤ by Clara cell 10-positive lung epithelial cells results in lung fibrosis. Both of these modalities overexpress TGF␤ in the lung, but their effects are not restricted to the epithelial cell population and have the potential for diverse effects on multiple cell populations. A remaining question has been the critical effector cells for TGF␤ signaling in the lungs. Prior to our studies, the most compelling evidence linking TGF␤ signaling in the epithelium to fibrosis comes from studies involving integrin-␣ v ␤ 6 , which is expressed only on epithelial cells and activates latent TGF␤ (20) . Mice deficient in the ␤ 6 -subunit have impaired activation of TGF␤ at the cell surface and are protected from lung fibrosis following bleomycin (37) and radiation (40) . While localized TGF␤ activation by integrin-␣ v ␤ 6 has the potential to directly activate other cells in the microenvironment, our transgenic model is designed such that targeted attenuation of TGF␤ signaling occurs only in lung epithelium. Taken together, these results demonstrate that lung epithelium can participate in lung fibrosis through expression of TGF␤ and signaling through TGF␤ receptors.
Prior studies by other investigators have also targeted deletion of TGF␤R2 in different cell populations in the lung. Recently, Hoyles et al. (19) reported that deletion of TGF␤R2 in resident lung fibroblasts in the first 2 wk after birth resulted in less lung fibrosis and decreased numbers of fibroblasts and fibrocytes when the mice were given intratracheal bleomycin as adults. When considered in conjunction with our current studies, this demonstrates how TGF␤ signaling in different cell populations can impact lung remodeling. In 2008, using a doxycycline-dependent transgenic system to delete TGF␤R2 in lung epithelium, Chen and colleagues (8) found postnatal lung developmental abnormalities, including retardation of alveolarization, enlargement of alveolar spaces, and decreased numbers of type I AECs. Recently, Li et al. (33) reported a model similar to ours, in which TGF␤R2 was deleted in lung epithelium using the Nkx2.1 promoter, instead of the SP-C promoter, Fig. 6 . Fewer total and epithelial-mesenchymal transition (EMT)-derived fibroblasts were observed in mice with TGF␤R2 deficiency in lung epithelium at 2 wk after bleomycin administration. Confocal microscopy was performed to detect fluorescent immunostaining for ␤-gal (green), S100A4 (red), and 4=,6-diamidino-2-phenylindole (DAPI, blue) in lung epithelial cell fate reporter mice with intact TGF␤R2 expression (SPC.Cre.Rosa) and TGF␤R2 deficiency (SPC.Cre.TGF␤R2.Rosa). A-H: representative images from lung sections from mice 2 wk after a single intratracheal dose of 0.08 U of bleomycin. Dual-fluorescent (yellow) cells indicate S100A4 ϩ fibroblasts derived from lung epithelial lineage. DIC, differential interference contrast. Magnification ϫ600. I: fewer total S100A4 ϩ cells and dual S100A4 ϩ /␤-gal ϩ cells per high-power field (HPF) were observed in mice with TGF␤R2 deficiency in lung epithelium (n ϭ 5 mice in each group). *P Ͻ 0.05 vs. SPC.Cre.Rosa.
and also noted enlargement of the alveolar spaces and a relative protection from bleomycin-induced lung fibrosis. In our present study, we also noted that the alveolar spaces of mice with lung epithelial cell deficiency of TGF␤R2 were slightly enlarged compared with littermate controls, but there was no evidence of true alveolar destruction, which is seen in emphysema, and, in fact, the mice appeared healthy and grew normally into adulthood. Whether this preexisting difference in alveolar size impacts the response to bleomycin is not known, but it may be a contributing factor.
AEC apoptosis has been implicated as a key component of pulmonary fibrosis in human forms of disease and in animal models (35, 49) . In IPF lung biopsies, AEC apoptosis is observed in regions adjacent to areas of heavy myofibroblast activity and collagen deposition (28, 50) . Animal studies have shown that bleomycin-induced lung injury is associated with AEC apoptosis (16, 27, 34) and that inhibition of apoptosis attenuates fibrosis (29, 53) . Recently, Sisson et al. (45) targeted diphtheria toxin to type II AECs, resulting in increased AEC death and the development of lung fibrosis. We noted that lung epithelial cell deficiency of TGF␤R2 was associated with a decrease in AEC death at 1 wk after bleomycin administration, and it is possible that this finding could explain, at least in part, the decreased fibrosis noted with this model. Taken together with the findings of Lee et al. (32) that overexpression of TGF␤ induces apoptosis in AECs, our data support the idea that TGF␤-induced AEC apoptosis is key for profibrotic effects of this cytokine.
TGF␤ is expressed by all cell types and, depending on the environment and cell type expressing this cytokine, can exact seemingly opposite effects. As such, it has been shown to have prominent anti-and proinflammatory effects (51) . However, classic studies in which TGF␤ signaling is disrupted imply that it has significant anti-inflammatory properties (43) . Mice expressing a null mutation for TGF␤1 have marked inflammation, leading to early lethality (26) . Furthermore, mice deficient in integrin-␣ v ␤ 6 , which activates latent TGF␤ to its active form, develop chronic inflammation in the lungs and skin (20) . In the present study, we noted an increase in the number of neutrophils and lymphocytes in BAL from mice with lung epithelial cell TGF␤R2 deficiency at 2 wk after bleomycin administration compared with mice with intact TGF␤R2 in lung epithelium, illustrating that epithelial cell-specific regulation of TGF␤ signaling impacts recruitment of inflammatory cells to the lung; however, the precise mechanism explaining this observation remains unclear. When considered in conjunction with the observation of increased apoptosis of AECs in mice with epithelial TGF␤R2 deficiency, our findings demonstrate that the extent of AEC cell death does not necessarily predict the level of the inflammatory response in the lungs after bleomycin administration.
TGF␤ has prominent effects on the lung fibroblast population, the effector cells responsible for the deposition of extracellular matrix in lung fibrosis. Multiple in vitro studies have shown that TGF␤ induces recruitment and activation of fibroblasts, leading to greater production of collagen, other extracellular matrix components, and other profibrotic cytokines (11, 41) . One of the ways that TGF␤ may lead to increased lung fibroblast numbers is through EMT. In 2005, Willis et al. (56) demonstrated that TGF␤1 exposure to RLE6TN rat lung epithelial cells could induce EMT in vitro. Subsequently, using a lung epithelial cell fate-mapping model, Kim et al. (23) demonstrated that the delivery of active TGF␤ by adenoviral vector resulted in EMT-derived lung fibroblasts in areas of fibrosis. In subsequent studies using cell fate-mapping models, Kim et al. and our laboratory demonstrated that EMT occurs in vivo in the bleomycin model (13, 24, 47) . Here, we demonstrate that lung epithelial cell TGF␤R2 deficiency is associated with a decrease in the number of lung fibroblasts, both total and derived via EMT. Interestingly, however, these studies demonstrate that EMT can occur even with interruption of the TGF␤ signaling cascade, and, in fact, the percentage of EMTderived S100A4
ϩ fibroblasts was similar in mice with lung epithelial cell TGF␤R2 deficiency and cell fate-mapping controls: 32 Ϯ 12% in SPC.Cre.TGF␤R2 fl/fl .Rosa.Stop.lacZ mice and 25 Ϯ 4% in SPC.Cre.Rosa.Stop.lacZ mice (P ϭ NS). Our study results suggest two interesting points regarding fibroblast recruitment: 1) TGF␤ signaling in AECs impacts EMT-derived fibroblasts and recruitment or proliferation of fibroblasts of other origin as well, and 2) EMT can occur in the absence of TGF␤ signaling in AECs. The mechanisms by which EMT occurs in the absence of TGF␤ signaling could be an interesting topic for future investigations.
In summary, our studies define a prominent role for epithelial TGF␤ signaling in regulating the fibrotic process in the lungs and suggest that specific targeting of this cell population could be beneficial in the development of new therapies for fibrotic lung diseases. 
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